Eliem Therapeutics

Manufacturing · Delaware, United States · 1-10 Employees

View Company Info for Free

Overview

Headquarters

2801 Centerville Rd # 1, Wilmington, Del...

Phone Number

(877) 354-3689

Revenue

$19.8 Million

Stock Symbol

ELYM

Industry

Manufacturing Pharmaceuticals Business Services Research & Development

About Eliem Therapeutics

Eliem Therapeutics is focused on developing novel therapies for neuronal excitability disorders to address unmet needs in chronic pain, psychiatry, epilepsy and other disorders of the peripheral and central nervous systems. These disorders often occur when neurons are overly excited or inhibited, leading to an imbalance, and our focus is on restoring homeostasis.Explore more
Eliem Therapeutics's Social MediaSIC Code 28,283NAICS Code 32,325Ticker NASDAQ: ELYMShow more

Eliem Therapeutics Org Chart

PhoneEmail
SL
United States flag for contact location.

Senior Director, Clinical Pharmacology

PhoneEmail
JG
United States flag for contact location.

Senior Director, Medical Affairs & Strategy

PhoneEmail
JK
United States flag for contact location.

Director

PhoneEmail
JM
United States flag for contact location.

Director, Assistant Controller

PhoneEmail
SD
United States flag for contact location.

Associate Director, MSAT

PhoneEmail
AP
United States flag for contact location.

Associate Director, CMC

Flame icon indicating likelihood to engage via phone.PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Compare Similar Companies to Eliem Therapeutics

Compare insights from companies similar to Eliem Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

Eliem Therapeutics

$19.8M
1-10
Public
$230M
2018
SL
Stacey LuoSenior Director, Clinical Pharmacology
<$5M
11-50
Public
$340.5M
2015
SV
Samara VioletSenior Director, Project Management
<$5M
11-50
Private
-
1983
BH
Bruce HugVice President, Clinical Development
<$5M
1-10
Private
$142M
2012
Davis Ryman, Chief Medical Officer at Aeovian Pharmaceuticals
Davis RymanChief Medical Officer
1-10
Public
$96.1M
2011
Matt Angel, President & Chief Executive Officer at Tempest Therapeutics
Matt AngelPresident & CEO
Illustration of an envelope

Eliem Therapeutics Tech Stack

A closer look at the technologies used by Eliem Therapeutics

Top Manufacturing Companies

Frequently Asked Questions Regarding Eliem Therapeutics

What is Eliem Therapeutics's stock symbol?
Eliem Therapeutics's stock symbol is ELYM
What is Eliem Therapeutics's official website?
Eliem Therapeutics's official website is www.eliemtx.com
What is Eliem Therapeutics's Revenue?
Eliem Therapeutics's revenue is $19.8 Million
What is Eliem Therapeutics's SIC code?
Eliem Therapeutics's SIC: 28,283
What is Eliem Therapeutics's NAICS code?
Eliem Therapeutics's NAICS: 32,325
How many employees does Eliem Therapeutics have?
Eliem Therapeutics has 1-10 employees
What industry does Eliem Therapeutics belong to?
Eliem Therapeutics is in the industry of: Manufacturing, Pharmaceuticals, Business Services
What is Eliem Therapeutics competition?
Eliem Therapeutics top competitors include: Bolt Biotherapeutics, Aeovian Pharmaceuticals, Tempest Therapeutics, Anthos Therapeutics
What technology does Eliem Therapeutics use?
Some of the popular technologies that Eliem Therapeutics uses are: WordPress.org, PHP, Google Cloud DNS, Google Cloud Web Serving
How do I contact Eliem Therapeutics?
Eliem Therapeutics contact info: Phone number: (877) 354-3689 Website: www.eliemtx.com
What does Eliem Therapeutics do?

Eliem Therapeutics is focused on developing novel therapies for neuronal excitability disorders to address unmet needs in chronic pain, psychiatry, epilepsy and other disorders of the peripheral and central nervous systems. These disorders often occur when neurons are overly excited or inhibited, leading to an imbalance, and our focus is on restori... ng homeostasis.Read More

What are Eliem Therapeutics social media links?
Eliem Therapeutics Linkedin page
Who invested in Eliem Therapeutics?
Eliem Therapeutics has 9 investors including Life Arc, RA Capital Management, Acorn Bioventures and Access Biotechnology.
Is Eliem Therapeutics a public company?
Yes, Eliem Therapeutics is a public company and is traded under the symbol ELYM
See more information about Eliem Therapeutics

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.